Advertisement
Wednesday, Nov 30, 2022
Outlook.com
Outlook.com

ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation

The trial, 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)', will be a multi-centre, adaptive platform trial on COVID patients, ICMR said on Friday.

ICMR To Pair With Oxford  For Clinical Trial Of COVID-19 Therapy Evaluation
Representational Image | PTI
ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation
outlookindia.com
2021-07-10T11:42:22+05:30

The Indian Council of Medical Research (ICMR) has proposed a collaborative endeavour  of conducting a clinical trial for 'randomised evaluation of COVID-19 therapy' with the University of Oxford. ICMR  expects the hospitals to come up with expression of intent .

According to the officials, the trial, 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)', is desihned to be a multi-centre, adaptive platform trial on Covid patients, 

"ICMR, Delhi, along with the University of Oxford is proposing to conduct a multi-centre, adaptive platform trial on COVID-19 patients, titled 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)," it said.

"An expression of intent is sought from institutions/hospitals with the facilities and capacity available to participate in the clinical trial which will enroll participants admitted in their hospitals."

According to the ICMR, the intervention arm of the trial will include baricitinib and the control arm will receive local standard of care. The trial will be initiated only after obtaining requisite regulatory and ethics approvals.

"Institutions which are interested to collaborate with ICMR on undertaking this trial may express their interest by providing the details," it said.

Informed consent has to be obtained from each patient before enrolment into the study.

The protocol of the study describes a randomised trial among patients hospitalised for COVID-19. All eligible patients are randomly allocated between several treatment arms, each to be given in addition to the usual standard of care in the participating hospital.

At the Indian sites, all participants aged 18 years or above will be allocated to baricitinib vs. no additional treatment. The interim trial results will be monitored by an independent Data Monitoring Committee. 

(With PTI Inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

In happy times and sad, Habba Khatun’s sensuous songs make both young and old emotional. With the never-ending conflict bringing tragedies to every doorstep, Habba’s lyrics of separation amplify their mourning.

How Indian Laws Govern People’s Right To Love And Live

How Indian Laws Govern People’s Right To Love And Live

In India, only those relationships between a man and a woman are considered to be legitimate when there is a marriage between the two.

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Virat Kohli, 33, had recently stepped down as India's T20I captain and was subsequently removed as the ODI captain.

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

A Mahila Congress leader, who is the face of the ‘Ladki Hoon, Lad Sakti Hoon’ campaign, however, has accused the party of anti-women bias after she was denied a ticket.

Advertisement